NIMH Clinical Pathway in Rural Appalachian School-based Health Clinics
Implementing the NIMH Clinical Pathway in Rural Appalachian School-based Health Clinics
1 other identifier
interventional
30
1 country
1
Brief Summary
This study will adapt and evaluate an evidence-based suicide risk screening and follow-up program in two school-based health centers in West Virginia. The suicide screening program is titled the "NIMH Clinical Pathway" and provides tools and procedures for routinely screening adolescents for suicide risk, completing risk assessments, safety planning, lethal means restriction, follow-up referrals, and other disposition planning as appropriate. Investigators aim to do the following:
- 1.Gather formative data from providers, parents, and youth to inform ways to adapt and implement the NIMH Clinical Pathway so that it can be effectively implemented in rural, Appalachian School-Based Health Centers (SBHCs).
- 2.Gather preliminary data regarding the feasibility, acceptability, and effectiveness of the adapted intervention.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Oct 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 2, 2024
CompletedFirst Submitted
Initial submission to the registry
January 29, 2025
CompletedFirst Posted
Study publicly available on registry
February 5, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 1, 2027
April 21, 2026
April 1, 2026
2.6 years
January 29, 2025
April 15, 2026
Conditions
Outcome Measures
Primary Outcomes (4)
Number of Patients Screened for Suicidal Risks-Site 1
Review of patient records for the number of patients that were asked about suicidal thoughts and/or behaviors during their visit. Review will occur for a total of 3 months during the Treatment as Usual Period.
Total period of 3 Months
Number of Patients Screened for Suicidal Risks-Site 2
Review of patient records for the number of patients that were asked about suicidal thoughts and/or behaviors during their visit. Review will occur for a total of 6 months during the Treatment as Usual Period.
Total period of 6 Months
Number of Patients Reporting Suicidal Risks-Site 1
Review of patient records for the number of patients that reported having suicidal thoughts and/or behaviors. Review will occur for a total of 12 months during the Intervention Period.
Total period of 12 Months
Number of Patients Reporting Suicidal Risks-Site 2
Review of patient records for the number of patients that reported having suicidal thoughts and/or behaviors. Review will occur for a total of 12 months during the Interventional Period
Total period of 12 Months
Secondary Outcomes (54)
Safety Planning Rates (Number)- Site 1
Initial Visit
Safety Planning Rates (Number)- Site 1
3 Month Follow Up Visit
Safety Planning Rates (Number)- Site 2
Initial Visit
Safety Planning Rates (Number)- Site 2
3 Month Follow Up Visit
Safety Planning Rates (Percentage)- Site 1
Initial Visit
- +49 more secondary outcomes
Study Arms (2)
Treatment As Usual (TAU)
NO INTERVENTIONReview all medical records for patients for the standard of care used at the facility for suicide assessment and risk. Determine if the enrolled patients were assessed and if risks are present.
NIMH Clinical Pathway
ACTIVE COMPARATORImplementation of an adapted/tailored version of the NIMH Clinical Pathway, which identifies a workflow and tools for routine suicide risk screening, assessment, safety planning and follow-up.
Interventions
Complete the implemented workflow and tools for suicide risk screening, assessment, safety planning and follow-up.
Eligibility Criteria
You may qualify if:
- Youth who are receiving services at the school-based health centers to participate
- Parents must be able to give legal consent for themselves and their children to participate
- Youth and Parent must be English-speaking
- Youth must also be able to give signed assent to participate
- Youth must be cognitively and medically able to participate in study activities
You may not qualify if:
- Youth in state custody will be excluded from study participation due to challenges related to obtaining legal consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
West Virginia University
Morgantown, West Virginia, 26505, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Mary Christensen, PhD, LICSW
West Virginia University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor and MSW Program Director
Study Record Dates
First Submitted
January 29, 2025
First Posted
February 5, 2025
Study Start
October 2, 2024
Primary Completion (Estimated)
May 1, 2027
Study Completion (Estimated)
May 1, 2027
Last Updated
April 21, 2026
Record last verified: 2026-04